Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

Summary

The purpose of this study is to test the drug bevacizumab in combination with cetuximab. Because this combination has not been tested in cancer patients before, results will be analyzed to see what effects the combination of bevacizumab with cetuximab has on esophageal cancer.

Timeline

Start

2008-10

Primary completion

2010-03

Completion

2012-03

Outcome

Outcome not reported

Stopped (Business): “lack of funding”

Drugs

Indications